|
|
5-day change | 1st Jan Change | ||
|
34.83 CNY |
-2.44% |
|
+9.43% | -29.01% |
Published on 08/07/2026
at 06:27 am EDT
MT Newswires
BrightGene Bio-Medical Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of raw materials, pharmaceutical intermediates and preparations, as well as providing related technology transfer. The Company’s products mainly cover therapeutic areas such as antiviral, antifungal, immunosuppression, respiratory system, anti-tumor and metabolism. Core products in the antiviral field include antifungal active pharmaceutical ingredients (APIs), Oseltamivir and others. The core products in the antifungal field include Caspofungin, Micafungin Sodium, Anidulafungin, Posaconazole. Core products in the immunosuppression field include Everolimus, Pimecrolimus and others. Core products in the respiratory system include Budesonide, Salmeterol, Fluticasone, and Tiotropium. Core products in the anti-tumor field include Eribulin and Lubitidin. Core products in the metabolic field include the Innovative drug BGM0504.
Annual profits – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
